Anthony J. Polverino Brainstorm Cell Therapeutics Inc. (BCLI) insider trading activity

Anthony J. Polverino is Director of BRAINSTORM CELL THERAPEUTICS INC.. Currently has a direct ownership of 25,730 shares of BCLI, which is worth approximately $57,377. The most recent transaction as insider was on Jan 01, 2025, when has been sold 24,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 25.7K

0.89% 3M change

0.89% 12M change

Total Value Held $57,377

Anthony J. Polverino Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 01 2025	BUY Grant, award, or other acquisition	-	24,000 Added 48.26%	25,730 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	3,882 Added 13.01%	25,960 Common Stock
Dec 15 2021	BUY Grant, award, or other acquisition	-	2,000 Added 8.31%	22,078 Common Stock
Dec 10 2021	BUY Grant, award, or other acquisition	-	4,216 Added 17.35%	20,078 Common Stock

Also insider at

ZYME

Zymeworks Inc. Healthcare

Chief Scientific Officer

AJP